Title:
LIQUID ANTIBODY FORMULATION WITH IMPROVED AGGREGATION PROPERTIES
Document Type and Number:
WIPO Patent Application WO/2014/100143
Kind Code:
A3
Abstract:
Disclosed here are methods and systems for improving the aggregation profile in a liquid antibody formulation. In one embodiment, the antibody is a fully monoclonal antibody that binds to Angiopoietin-2.
Inventors:
MALIK PRIYANKA (US)
SHAH AMBARISH (US)
TUESCA ANTHONY (US)
SHAH AMBARISH (US)
TUESCA ANTHONY (US)
Application Number:
PCT/US2013/076062
Publication Date:
August 14, 2014
Filing Date:
December 18, 2013
Export Citation:
Assignee:
MEDIMMUNE LLC (US)
International Classes:
A61K39/395; A61P35/00
Domestic Patent References:
| WO2012089778A1 | 2012-07-05 |
Foreign References:
| US20110044998A1 | 2011-02-24 | |||
| US7521053B2 | 2009-04-21 | |||
| US8231876B2 | 2012-07-31 |
Other References:
See also references of EP 2934588A4
Attorney, Agent or Firm:
COHEN, Jared et al. (LLCOne Medimmune Wa, Gaithersburg MD, US)
Download PDF:
Previous Patent: MICRO-REBAR CONCRETE REINFORCEMENT SYSTEM
Next Patent: HOLDER ASSEMBLY FOR WIPER ASSEMBLIES
Next Patent: HOLDER ASSEMBLY FOR WIPER ASSEMBLIES